RN6G
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RN6G, covering 2015-03-31 to 2022-05-12. Get the full timeline:
Most recent: Clinical Trial Update: Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy [Phase 1]